2,534
+1.93%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About WDB coco Co
Its shares trade on Tokyo Stock Exchange under the ticker 7079.T. It has been listed since 25 December 2019. In the fiscal year to 31 March 2026, it reported revenue of ¥4.82bn and net income of ¥679.3m. At that date it held total assets of ¥5.70bn and shareholders' equity of ¥4.78bn.
WDB coco Co., Ltd. engages in the safety information management business. The company is headquartered in Chuo-Ku, Tokyo-To. The company went IPO on 2019-12-25. The firm is engaged in the provision of safety information management service as an agent and support for drug development, document support service, development support service and clinical development support service. The safety information management service provides support services such as input, evaluation drafting and report drafting. The document support service provides support services from QC (quality assurance) and translation of documents and materials necessary for marketing approval to PMDA (Pharmaceuticals and Medical Devices Agency) to the creation of approval application called CTD (Common Technical Document). The development support service provides services such as survey form management, filing of survey-related documents and call center operations. The clinical development support service provides support services for clinical trial related work.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Listed since
- 25 Dec 2019
- Employees
- 471
- Website
- wdbcoco.com ↗
Leadership
Pay as last reported
- Mr. Haruhiko TaniguchiPresident, Representative Director, since 2014
- Ms. Hatsune NishimoriDirector of Contract Sales, Director, since 2019
- Mr. Motoyuki FujiwaraChief Director of Administration, Director, since 2019
- Mr. Toshimitsu NakanoDirector
- Mr. Masashi OoiIndependent Director
- Mr. Kenta YokogawaIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- WDB coco Co Ltd employs 471 full-time employees in Chuo-Ku, Tokyo-To.
- The company provides safety information management services for drug development and clinical trials.
- WDB coco Co Ltd supports document services for PMDA approval applications and CTD creation.
Weaknesses
- The company has no listed competitors in the Japanese market for safety information management.
- WDB coco Co Ltd lacks a global presence beyond Japan.
- The firm's business is limited to Japan's Pharmaceuticals and Medical Devices Agency regulations.
Opportunities
- The Japanese Life Sciences Tools & Services sector is growing steadily.
- WDB coco Co Ltd can expand into clinical development support services for global markets.
- The increasing demand for CTD creation services in Japan presents new opportunities.
Threats
- The PMDA approval process may become more complex with new regulations.
- WDB coco Co Ltd faces potential competition from international firms entering Japan.
- Changes in Japanese healthcare policies could impact the safety information management market.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.